AbCellera Biologics Inc. ABCL Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s shares (diluted)?
- AbCellera Biologics Inc. (ABCL) reported shares (diluted) of 303.1M in Q1 2026.
- How has AbCellera Biologics Inc.'s shares (diluted) changed year-over-year?
- AbCellera Biologics Inc.'s shares (diluted) increased by 1.8% year-over-year, from 297.7M to 303.1M.
- What is the long-term trend for AbCellera Biologics Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), AbCellera Biologics Inc.'s shares (diluted) has grown at a 0.1% compound annual growth rate (CAGR), from 1.2B to 1.2B.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.